This website is intended for healthcare professionals only

Making medicines safer for children—guidance for the use of unlicensed medicines in paediatric patients

Disclaimer: Information intended for healthcare professionals only. This guideline has been developed by MGP Ltd, the publishers of Guidelines, and the Working Party was convened by them. Rosemont Pharmaceuticals Ltd was able to recommend experts for the working party group and comment on the scope and title, with final decisions resting with the Chair. Rosemont Pharmaceuticals Ltd had the opportunity to comment on the technical accuracy of this guideline but the content is independent of and not influenced by Rosemont Pharmaceuticals Ltd.



COPD diagnosis, management and prevention
Global Initiative for Chronic Obstructive Lung Disease

Choosing an appropriate inhaler device for the treatment of adults with asthma or COPD
Development Group: Usmani, Capstick, Chowhan, & Scullion.
This management algorithm was developed by a multidisciplinary expert panel: Usmani et al with the support of a grant from Chiesi Ltd.

Summary of the management of asthma in children (from the British guideline on the management of asthma)
The British Thoracic Society & Scottish Intercollegiate Guidelines Network

Summary of the management of asthma in adults (from the British guideline on the management of asthma)
The British Thoracic Society & Scottish Intercollegiate Guidelines Network

Rosacea—primary care treatment pathway
Primary Care Dermatology Society

Choosing an appropriate inhaler device for the treatment of adults with asthma or COPD
Development Group: Usmani, Capstick, Chowhan, & Scullion.
This management algorithm was developed by a multidisciplinary expert panel: Usmani et al with the support of a grant from Chiesi Ltd.

COPD diagnosis, management and prevention
Global Initiative for Chronic Obstructive Lung Disease



Visit our NEW site!

Guidelines for Nurses provides current, credible summaries and feature articles developed especially for nurses.